Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Noa
    Member
    • Jun 2011
    • 62

    #1

    Cuffdiff with biological replicates vs individual samples not adding up.

    I am performing differential expression analysis of three different experimental conditions, each of which has 4 biological replicates, and was trying to do this using cuffdiff. We are really only interested initially in looking at currently annotated genes. I am using the Ensembl genome and gtf files from iGenomes.

    STEP 1: tophat
    I initially (after quality filtering fastq files) ran tophat with the following command:
    For the first run (to make a transcriptome index from the GTF file):
    tophat -p 8 -G Ensembl_genes.gtf --transcriptome-index=GTF_transcriptome_index/known -o SW-1B-1.tophat --no-novel-juncs --library-type=fr-firststrand genome SW-1B-1_AC_QF_FINAL.fastq;

    for the rest of the 11 tophat runs using previously built transcriptome index
    for k in {2..12}; do
    tophat -p 8 --transcriptome-index=GTF_transcriptome_index/known -o SW-1B-$k.tophat --no-novel-juncs --library-type=fr-firststrand genome SW-1B-$k.AC_QF_FINAL.fastq;

    STEP 2: cuffdiff
    Then I ran cuffdiff in one of two ways. Firstly, specifying three replicate groups (named T,P,N) as such:
    cuffdiff -o Diff_OUT -v -b genome.fa -p 8 -L T,P,N -u Ensembl_genes.gtf \
    ./SW-1B-1.tophat/accepted_hits.bam,./SW-1B-4.tophat/accepted_hits.bam,./SW-1B-7.tophat/accepted_hits.bam,./SW-1B-10.tophat/accepted_hits.bam \
    ./SW-1B-2.tophat/accepted_hits.bam,./SW-1B-5.tophat/accepted_hits.bam,./SW-1B-8.tophat/accepted_hits.bam,./SW-1B-11.tophat/accepted_hits.bam \
    ./SW-1B-3.tophat/accepted_hits.bam,./SW-1B-6.tophat/accepted_hits.bam,./SW-1B-9.tophat/accepted_hits.bam,./SW-1B-12.tophat/accepted_hits.bam

    Secondly as we wanted to see the FPKMs of each sample separately we ran cuffdiff on each sample separately:
    cuffdiff -o Diff_OUT_separate -v -b genome.fa -p 8 -L 1T,2T,3T,4T,1P,2P,3P,4P,1N,2N,3N,4N -u Ensembl_genes.gtf \
    ./SW-1B-1.tophat/accepted_hits.bam \
    ./SW-1B-4.tophat/accepted_hits.bam \
    ./SW-1B-7.tophat/accepted_hits.bam \
    ./SW-1B-10.tophat/accepted_hits.bam \
    ./SW-1B-2.tophat/accepted_hits.bam \
    ./SW-1B-5.tophat/accepted_hits.bam \
    ./SW-1B-8.tophat/accepted_hits.bam \
    ./SW-1B-11.tophat/accepted_hits.bam \
    ./SW-1B-3.tophat/accepted_hits.bam \
    ./SW-1B-6.tophat/accepted_hits.bam \
    ./SW-1B-9.tophat/accepted_hits.bam \
    ./SW-1B-12.tophat/accepted_hits.bam

    Step3: confusion!
    Now I am really confused: The analysis using replicates as three groups gave us only a handful of significantly expressed genes.


    When I look at the FPKMs of these genes in the cuffdiff which ran each sample separately- they don’t add up to what I am seeing when the samplse are grouped as biological replicates.

    The gene NCKX1 was supposed to be of average FPKM 2 in T and 7.77 in P; in the cuffdiff run separately this seems to match up OK with the individual FPKMs.
    But the gene RGD1359290 was supposed to go from 2.6 in T to 18.8 in P and 17.4 in N; in the individual sampes nothing is even remotely near those values in P, and there is only one high FPKM value in N.

    Would love to know what is going on and whether I can trust these data!
    Thanks
    Noa
    Attached Files

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
40 views
0 reactions
Last Post SEQadmin2  
Working...